Equillium (EQ) Cash from Financing Activities (2018 - 2026)

Equillium (EQ) reported Cash from Financing Activities of $35.3 million for Q1 2026, up 38741.76% year-over-year from N/an in Q1 2025, and up 12389.75% quarter-over-quarter from $283000.0 in Q4 2025.

Equillium (EQ) Cash from Financing Activities (2018 - 2026) Analysis & Trends

Equillium (EQ) has 9 years of Cash from Financing Activities data on file, last reported at $35.3 million in Q1 2026.

  • Cash from Financing Activities for Q1 2026 came in at $35.3 million, up 38741.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $65.7 million (up 26929.63% YoY), and the FY2025 annual result was $30.4 million, up 18453.05% from the prior year.
  • Cash from Financing Activities climbed to $35.3 million in Q1 2026 per EQ's latest filing, from $283000.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $35.3 million in Q1 2026 and troughed at -$7.6 million in Q2 2023.
  • A 5-year average of $5.0 million and a median of $73000.0 in 2024 frame the typical range for Cash from Financing Activities.
  • The sharpest annual moves came in 2022 and 2026: Cash from Financing Activities sank 702.67% in 2022, then jumped 38741.76% in 2026.
  • A 5-year view of Cash from Financing Activities shows it stood at -$1.4 million in 2022, then soared by 105.83% to $79000.0 in 2023, then dropped by 7.59% to $73000.0 in 2024, then jumped by 287.67% to $283000.0 in 2025, then surged by 12389.75% to $35.3 million in 2026.
  • Business Quant data shows EQ's Cash from Financing Activities at $35.3 million in Q1 2026, $283000.0 in Q4 2025, and $30.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 7.00 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -600,000.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 53,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -538.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - 85,464.43
10 Equillium 293.17 Mn 232.78 Mn - 35.35 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 35.35 Mn
Mar 31, 2026 35.35 Mn
Dec 31, 2025 283,000.00
Dec 31, 2025 283,000.00
Sep 30, 2025 30.07 Mn
Sep 30, 2025 30.07 Mn
Jun 30, 2025 -16,000.00
Jun 30, 2025 -16,000.00
Mar 31, 2025 91,000.00
Mar 31, 2025 91,000.00
Dec 31, 2024 73,000.00
Dec 31, 2024 73,000.00
Dec 31, 2023 79,000.00
Dec 31, 2023 79,000.00
Sep 30, 2023 -260,000.00
Sep 30, 2023 -260,000.00
Jun 30, 2023 -7.62 Mn
Jun 30, 2023 -7.62 Mn
Mar 31, 2023 -1.43 Mn
Mar 31, 2023 -1.43 Mn